Core Viewpoint - U.S. stock markets experienced a significant rally in 2024 following a strong bull run in 2023, but faced a downturn in February 2025, with major indexes declining [1][2]. Market Conditions - Concerns regarding the Trump administration's tariff and trade policies and their potential impact on U.S. economic growth and inflation persist [2]. - Ongoing geopolitical conflicts in the Middle East and other regions contribute to market uncertainty [2]. Stock Performance - Five stocks identified as having strong price momentum include EverQuote Inc. (EVER), Jazz Pharmaceuticals plc (JAZZ), The Progressive Corp. (PGR), Sony Group Corp. (SONY), and NatWest Group plc (NWG) [3][10][12][15][20]. - EverQuote's stock price increased by 33.1% in the past four weeks, with expected revenues between 160 million for Q1 2025 [11][12]. - Jazz Pharmaceuticals saw a 15.4% rise in stock price, with an expected earnings growth rate of 10.6% for the current year [14]. - The Progressive Corp. experienced a 14.4% stock price appreciation, with an expected earnings growth of 7.3% [16]. - Sony Group's stock price advanced by 13.8%, with an expected earnings growth rate of 15.6% for the next year [19]. - NatWest Group's stock price gained 13.5%, with an expected earnings growth of 6.8% [21]. Investment Strategy - A screening process is suggested to identify potential winning stocks, focusing on criteria such as percentage change in price over 4 and 12 weeks, Zacks Rank, broker ratings, and price proximity to 52-week highs [6][7][8][9]. - This screening narrowed down the stock selection from over 7,700 to just 15 candidates [9].
5 Stocks With Recent Price Strength Defying a Weak February